REFERENCES
- Moreira RK. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med. 2007;131:1728–1734.
- Liu X, Hu H, Yin JQ. Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int. 2006;26:8–22.
- Paradis V, Dargere D, Bonvoust F, Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest. 2002;82:767–774.
- Zheng S, Chen A. Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol. 2006;290:G883–G893.
- Zhang C, Zhu Y, Wan J, Effects of Ginkgo biloba extract on cell proliferation, cytokines and extracellular matrix of hepatic stellate cells. Liver Int. 2006;26:1283–1290.
- Fu M, Zhu X, Wang Q, Platelet-derived growth factor promotes the expression of peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells by a phosphatidylinositol 3-kinase/Akt signaling pathway. Circ Res. 2001;89:1058–1064.
- Marra F, Efsen E, Romanelli RG, Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology. 2000;119:466–478.
- Galli A, Crabb D, Price D, Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology. 2000;31:101–108.
- Miyahara T, Schrum L, Rippe R, Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J Biol Chem. 2000;275:35715–35722.
- Xu J, Fu Y, Chen A. Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol. 2003;285:G20–G30.
- Jiang DJ, Jiang JL, Zhu HQ, Demethylbellidifolin preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. J Ethnopharmacol. 2004;93:295–306.
- Jiang DJ, Dai Z, Li YJ. Pharmacological effects of xanthones as cardiovascular protective agents. Cardiovasc Drug Rev. 2004;22:91–102.
- Chang CH, Lin CC, Hattori M, Effects on anti-lipid peroxidation of Cudrania cochinchinensis var. gerontogea. J Ethnopharmacol. 1994;44:79–85.
- Madan B, Singh I, Kumar A, Xanthones as inhibitors of microsomal lipid peroxidation and TNF-alpha induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs). Bioorg Med Chem. 2002;10:3431– 3436.
- Jiang DJ, Jiang JL, Tan GS, Demethylbellidifolin inhibits adhesion of monocytes to endothelial cells via reduction of tumor necrosis factor alpha and endogenous nitric oxide synthase inhibitor level. Planta Med. 2003;69:1150–1152.
- Jiang DJ, Tan GS, Zhou ZH, Protective effects of demethylbellidifolin on myocardial ischemia-reperfusion injury in rats. Planta Med. 2002;68:710–713.
- Chen A, Zhang L, Xu J, The antioxidant (-)-epigallocatechin-3-gallate inhibits activated hepatic stellate cell growth and suppresses acetaldehyde-induced gene expression. Biochem J. 2002;368:695–704.
- Fu Y, Zheng S, Lin J, Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol. 2008;73:399–409.
- Kim Y, Ratziu V, Choi SG, Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem. 1998;273:33750– 33758.
- Frazier K, Williams S, Kothapalli D, Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 1996;107:404–411.